|
|
 |
|
Viewing report
|
|
|
|
Analysis Report on China’s Ferrous Sulphate & Anti-anemia Medicine Market
Sunfaith China Ltd, March 2005, Pages: 12
With the stable and rapid growth of China’s economy in the recent decade, China’s medicine industry, one of the major national industries, has maintained strong growth momentum.
Medicine industry is closely related to the development of consumer market capacity. Increase in China’s GDP per capita and residential income stimulate the demand on medical services.
China is one of the regions with relatively high anemia incidence rate in the world. In 2003, there are about 200 million people suffering the anemia disease in China, accounting for 15%-20% of the total population.
Currently, products with the following five effects are very popular in China’s health care product market: blood-flourish, calcium-flourish, kidney-care, skin-care and brain -care. The relevant products can be found everywhere in China market. The blood-flourish health care products account for 6.25% in the total health care product market.
There are few pharmaceutical enterprises engaged in the production of Ferrous Sulfate medicines in China due to the simple manufacturing crafts, low prices and limited market demands. According to China Medicine Statistical Annals, there is only one pharmaceutical enterprise in China engaged in the production of Ferrous Sulfate medicines. Many other enterprises have turned to manufacturing of the compound hematinic medicines containing Ferrous Sulfate so as to increase the profits.
Product samples
A sample for this product is available. Please Login/Register to download this sample.
|
|
|
|
